These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8817393)

  • 21. CD34+ leukemic cells assessed by different CD34 monoclonal antibodies.
    Lanza F; Moretti S; Castagnari B; Latorraca A; Rigolin GM; Bardi A; Castoldi G
    Leuk Lymphoma; 1995; 18 Suppl 1():25-30. PubMed ID: 7496351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of CD34 epitopes in AML.
    Sutherland R; Keeney M; Gratama JW
    Haematologica; 2003 Jun; 88(6):ELT22; author reply ELT23. PubMed ID: 12801861
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of murine monoclonal antibody against synthetic peptide of CD34.
    Maleki LA; Majidi J; Baradaran B; Abdolalizadeh J; Akbari AM
    Hum Antibodies; 2013; 22(1-2):1-8. PubMed ID: 24284303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of two new monoclonal antibodies against the CD34 molecule.
    Barrande C; Traore Y; Szekeres G; Hirn J
    Hybridoma; 1993 Apr; 12(2):203-13. PubMed ID: 7686138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of CD34+ cells in bone marrow by flow cytometry.
    Trischmann TM; Schepers KG; Civin CI
    J Hematother; 1993; 2(3):305-13. PubMed ID: 7522885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention of progenitor cell function in CD34+ cells purified using a novel O-sialoglycoprotease.
    Marsh JC; Sutherland DR; Davidson J; Mellors A; Keating A
    Leukemia; 1992 Sep; 6(9):926-34. PubMed ID: 1381456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic peculiarities of mobilized stem (CD34+) cells in blood from patients with severe spinal cord injury.
    Tupitsyn NN; Yaryghin VN; Bryukhovetskiy AS; Grivtsova LY; Mentkevich GL; Dolgopolov IS; Zaitsev AY; Davydov MI
    J Biol Regul Homeost Agents; 2006; 20(1-2):36-40. PubMed ID: 18088553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34 expression on platelets.
    Lewandowska K; Kaplan D; Husel W
    Platelets; 2003 Mar; 14(2):83-7. PubMed ID: 12745450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.
    Gajkowska A; Oldak T; Jastrzewska M; Machaj EK; Walewski J; Kraszewska E; Pojda Z
    Folia Histochem Cytobiol; 2006; 44(1):53-60. PubMed ID: 16584093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells.
    Ziegler BL; Thoma SJ; Lamping CP; Valtieri M; Müller R; Samoggia P; Bühring HJ; Peschle C; Fliedner TM
    Cytometry; 1996 Sep; 25(1):46-57. PubMed ID: 8875054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue.
    Quirici N; Scavullo C; de Girolamo L; Lopa S; Arrigoni E; Deliliers GL; Brini AT
    Stem Cells Dev; 2010 Jun; 19(6):915-25. PubMed ID: 19929314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
    Sumikuma T; Shimazaki C; Inaba T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Nakagawa M
    Br J Haematol; 2002 Apr; 117(1):238-44. PubMed ID: 11918561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues.
    Titley I; Healy LE; Scott M; Amos TA; Gordon MY
    Bone Marrow Transplant; 1995 Oct; 16(4):611-6. PubMed ID: 8528180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD34 molecule epitope distribution on cells of haematopoietic origin.
    Steen R; Egeland T
    Leuk Lymphoma; 1998 Jun; 30(1-2):23-30. PubMed ID: 9669673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens.
    de Boer F; Dräger AM; Van Haperen MJ; van der Wall E; Kessler F; Huijgens PC; Pinedo HM; Schuurhuis GJ
    Br J Haematol; 2000 Dec; 111(4):1138-44. PubMed ID: 11167753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mAb against a human CD34 peptide reacts with the native protein on CD34+ cells.
    Shams M; Jeddi-Tehrani M; Notash Haghighat F; Bayat AA; Mahmoudian J; Rezvani MR
    Iran J Immunol; 2013 Dec; 10(4):259-66. PubMed ID: 24375067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
    Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells.
    Giesert C; Almeida-Porada G; Scheffold A; Kanz L; Zanjani ED; Bühring HJ
    Ann N Y Acad Sci; 2001 Jun; 938():175-83. PubMed ID: 11458505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early stages of CD34+ differentiation during radiation exposure].
    Bieliaieva NV
    Lik Sprava; 2006 Jun; (4):20-6. PubMed ID: 17100234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.